Pharmacy Benefit Management

From Drug Benefit News - While PBMs have been giving significant attention to the rising cost of compounded medications (see story, above), another traditional category that’s driving trend at an alarming rate is diabetes. According to recent trend reports, PBMs observed double-digit increases in diabetes drug costs in 2013, largely due to inflation. Read more

From Drug Benefit News - While PBMs have begun making bold moves to manage the cost of compounded medications through coverage changes and even contract terminations (see story, p. 1), a new limited network has popped up that seeks to preserve these specialized medicines as a covered benefit by excluding the “players that have given the compounding industry a bad name.” United Compounding Network (UCN) is meant to be a closed, limited network that includes… Read more

Pharmacy Benefit Management Blog

By Lauren Flynn Kelly - July 15, 2014
In the July 11 issue of Drug Benefit News, we profiled the complex category of diabetes treatments, which has some 380 products in various stages of clinical development. But with a wide array of treatment options comes the challenge of keeping patients on their medications. Next to high...
By Lauren Flynn Kelly - June 30, 2014
I have a confession to make. After all the articles I’ve written and webinars I’ve hosted on payer efforts to curb the use of manufacturer-offered drug copay coupons, I finally used an actual copay coupon the other day. But I just barely made it through the process, thanks to an incredibly long and...
By Lauren Flynn Kelly - June 5, 2014
Earlier this week, the Pharmaceutical Care Management Association (PCMA) called attention to a new National Center for Policy Analysis (NCPA) report that makes the case against any willing pharmacy participating in specialty pharmacy networks. “Specialty drugs require a level of experience and...

It's quick and easy to sign up for FREE access to!

Why do I need to register?